High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis

BackgroundImmunotherapy has become the standard of care for non-small cell lung cancer (NSCLC) patients. Some patients experience primary resistance to immunotherapy. Currently, we lack a marker of resistance to immunotherapy. Myeloid-derived suppressive-like cells (MDSCs) can reduce tumor response...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Giuseppe Bronte, Elisabetta Petracci, Serena De Matteis, Matteo Canale, Ilaria Zampiva, Ilaria Priano, Paola Cravero, Kalliopi Andrikou, Marco Angelo Burgio, Paola Ulivi, Angelo Delmonte, Lucio Crinò
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2022-04-01
Col·lecció:Frontiers in Immunology
Matèries:
myeloid-derived suppressive cells
primary resistance
immunotherapy
non-small cell lung cancer
immune checkpoint inhibitors
Accés en línia:https://www.frontiersin.org/articles/10.3389/fimmu.2022.866561/full
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars